Research Article
Predictive Values of Serum IL-33 and sST2 in Endotypes and Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps
Table 3
Association between serum IL-33 and ST2 levels and clinical parameters in CRSwNP patients.
| Variable | Serum IL-33 level | Serum ST2 level | | value | | value |
| Age | -0.212 | 0.879 | -0.187 | 0.792 | BMI | 0.102 | 0.549 | 0.092 | 0.568 | B-EOS count (106/L) | 0.417 | 0.006 | 0.489 | 0.002 | B-EOS percentage (%) | 0.389 | 0.027 | 0.402 | 0.009 | Lund-Mackay score | 0.187 | 0.613 | 0.192 | 0.598 | Lund-Kennedy score | 0.078 | 0.914 | 0.067 | 0.896 | VAS score | 0.193 | 0.734 | 0.217 | 0.698 | T-EOS count | 0.612 | <0.001 | 0.594 | <0.001 | T-EOS percentage (%) | 0.656 | <0.001 | 0.702 | <0.001 | Serum IL-33 level (pg/mL) | — | — | 0.793 | <0.001 | Serum ST2 level (ng/mL) | 0.793 | <0.001 | — | — |
|
|
ST2: suppressor of tumorigenicity 2; CRSwNP: chronic rhinosinusitis with nasal polyps; BMI: body mass index; B-EOS: blood eosinophil; VAS: visual analogue scale; T-EOS: tissue eosinophil.
|